RIG
58
-2
MOS
36
-2
O
32
12
HES
62
3
ADT
37
4
ABBV
68
4
PCG
81
3
SRE
40
3
PWR
67
2
AXP
48
-4
MNST
59
5
MSI
64
4
VRSK
22
11
CI
42
3
ECL
55
5
EQIX
52
5
ABT
36
6
VRTX
66
3
PPG
53
4
NFLX
51
3
RIG
58
-2
MOS
36
-2
O
32
12
HES
62
3
ADT
37
4
ABBV
68
4
PCG
81
3
SRE
40
3
PWR
67
2
AXP
48
-4
MNST
59
5
MSI
64
4
VRSK
22
11
CI
42
3
ECL
55
5
EQIX
52
5
ABT
36
6
VRTX
66
3
PPG
53
4
NFLX
51
3
Financhill
Back

Karuna Therapeutics Quote, Financials, Valuation and Earnings

Get Instant Access To Today's Top Options List!

View this list for FREE now!
Buy
52

KRTX
Karuna Therapeutics

Last Price:
182.59
Seasonality Move:
21.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Is it possible to have a crash proof portfolio?

See important Reg A disclosures: Masterworks.com/cd

Karuna Therapeutics Price Quote

$182.59
+0.17 (+3.61%)
(Updated: March 25, 2023 at 5:20 AM ET)

Karuna Therapeutics Key Stats

Buy
52
Karuna Therapeutics (KRTX) is a Buy
Day range:
$174.40 - $183.34
52-week range:
$92.26 - $278.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.65%
Volume:
917.5K
Avg. volume:
495.8K
1-year change:
54.51%
Market cap:
$6.4B
Revenue:
$10.6M
EPS:
$-8.72

How Much Does Karuna Therapeutics Make?

Data Unavailable

Is Karuna Therapeutics Growing As A Company?

  • What Is Karuna Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.86%
  • What Is Karuna Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Karuna Therapeutics Stock Price Performance

What Is Karuna Therapeutics 52-Week High & Low?

Karuna Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Karuna Therapeutics?

Is Karuna Therapeutics Cash Flow Positive?

  • What Is KRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$228M
  • What Is Karuna Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $855.8M
  • What Is Karuna Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$586.4M

Karuna Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    KRTX return on invested capital is -37.64%
  • What Is Karuna Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -36.1%
  • What Is KRTX Return On Equity?
    ROE is a measure of profitability and is -37.64%

Karuna Therapeutics Earnings Date & Stock Price

Karuna Therapeutics Competitors

Karuna Therapeutics Dividend Yield

Data Unavailable

Karuna Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.9%
Revenue: -85.72% 0%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 278.10
Upside from Last Price: 52.45%

Major Shareholders

  • How many KRTX shares are owned by institutional investors?
    51.4M KRTX shares are owned by institutional investors
  • How many KRTX shares are owned by insiders?
    261.7K KRTX shares are owned by insiders